Improving Access to SUD Treatment in Justice-Involved Setting

In a New Webinar, the American Medical Association and Manatt Health Lead a Panel of Experts Examining How Medicine, Law and Policy Can Converge to Support Substance Use Disorder (SUD) Treatment in Justice-Involved Populations.

Since the landmark case of Estelle v. Gamble in 1976, the Supreme Court has held that incarcerated individuals have the right to adequate medical care. Even so, it remains common for jail and prison officials to deny substance use disorder treatment to justice-involved individuals—despite the fact that many may be incarcerated because of their SUD or related mental health issues.

In a new webinar, the American Medical Association (AMA) and Manatt Health will lead a dynamic panel—including experts from Johns Hopkins School of Medicine, the American Civil Liberties Union (ACLU) and the state of North Carolina—discussing the medical, legal and policy imperatives for ensuring justice-involved populations have access to SUD treatment. Key topics that the program will cover include:

  • The importance of providing evidence-based medical treatment of SUDs to justice-involved individuals, including both those involved in jail diversion programs and those entering or currently incarcerated in a jail or prison.
  • Actionable data and policies for protecting SUD patients in justice-involved settings.
  • The medical and legal foundation supporting SUD treatment for justice-involved populations.
  • Key data on clinical research on pregnant women in jail or prison, as well as their legal rights to SUD treatment.
  • A pioneering initiative in North Carolina to provide access to evidence-based SUD treatment in jails and prisons—and what other states can learn from this innovative program.

There is no legal, medical or other reason to deny SUD treatment to justice-involved populations. Yet that practice continues—in spite of an increasing number of court rulings that medications for opioid use disorder must be provided to incarcerated individuals. Even if you can’t make our original airing on April 20, register free now, and you’ll receive a link to view the program on demand.

P.S. For more information on leading-edge practices to remove barriers to evidence-based SUD treatment, click here to download a free copy of the AMA’s and Manatt Health’s recent white paper, “National Roadmap on State-Level Efforts to End the Drug Overdose Epidemic.”


Jocelyn Guyer, Managing Director, Manatt Health


Patrice A. Harris, MD, MA, Immediate Past President, AMA; Chair, AMA Opioid Task Force


Carolyn Sufrin, MD, PhD, Assistant Professor of Gynecology and Obstetrics, Johns Hopkins University School of Medicine
Emma Bond, JD, Legal Director, ACLU of Maine
Jessie Rossman, JD, Staff Attorney, ACLU of Massachusetts
Elyse Powell, PhD, State Opioid Coordinator, North Carolina Department of Health and Human Services

Date and Time

Tuesday, April 20

If you would like to receive an audio transcript of this webinar due to accessibility issues, please email us at

This program does not constitute legal advice, nor does it establish an attorney-client relationship. Views expressed by presenters are strictly their own and should not be construed to be the views of Manatt or attributed to Manatt.



pursuant to New York DR 2-101(f)

© 2024 Manatt, Phelps & Phillips, LLP.

All rights reserved